当前位置:首页 - 行情中心 - 药明康德(603259) - 财务分析

药明康德

(603259)

  

流通市值:1085.47亿  总市值:1250.48亿
流通股本:25.46亿   总股本:29.33亿

药明康德(603259)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2023年年度实现净利润97.00亿元,每股收益3.27元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2023年年度最新股东权益5551744.54万元,未分配利润2577347.90万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2023年年度最新总资产7366934.93万元,负债1815190.39万元。

利润表
报告期2023-12-312023-09-302023-06-302023-03-31
营业总收入40,340,806,877.0429,541,326,133.5818,871,285,497.628,963,741,607.53
营业总成本28,708,590,806.3820,390,754,912.9413,155,192,160.226,775,228,643.47
营业利润11,872,285,906.479,807,416,477.556,412,440,472.192,615,354,834.65
利润总额11,831,990,991.159,781,966,276.666,395,212,941.232,608,872,752.98
净利润9,700,260,033.278,148,647,084.335,356,896,235.842,185,804,643.61
其他综合收益86,920,855.5-543,935,758.12-513,668,492.23-17,915,814.4
综合收益总额9,787,180,888.777,604,711,326.214,843,227,743.612,167,888,829.21
资产负债表
报告期2023-12-312023-09-302023-06-302023-03-31
流动资产合计30,422,470,960.8229,777,189,611.6627,580,065,949.0127,502,389,642.3
非流动资产合计43,246,878,346.341,982,091,626.2741,739,067,781.6740,685,698,982.32
资产总计73,669,349,307.1271,759,281,237.9369,319,133,730.6868,188,088,624.62
流动负债合计14,756,296,165.5716,979,131,571.4616,363,159,319.2915,786,215,710.63
非流动负债合计3,395,607,728.812,791,747,274.142,757,192,800.132,570,870,388.83
负债合计18,151,903,894.3819,770,878,845.619,120,352,119.4218,357,086,099.46
归属于母公司股东权益合计55,122,453,910.7351,586,653,307.0149,825,285,290.9949,474,882,627.12
股东权益合计55,517,445,412.7451,988,402,392.3350,198,781,611.2649,831,002,525.16
负债和股东权益合计73,669,349,307.1271,759,281,237.9369,319,133,730.6868,188,088,624.62
现金流量表
报告期2023-12-312023-09-302023-06-302023-03-31
经营活动现金流入小计42,272,825,974.731,562,847,90120,308,833,471.610,435,310,810.01
经营活动现金流出小计28,885,914,195.9321,246,060,041.4314,710,652,737.457,407,981,551.83
经营活动产生的现金流量净额13,386,911,778.7710,316,787,859.575,598,180,734.153,027,329,258.18
投资活动现金流入小计2,899,446,215.911,557,031,673.361,151,810,129.58251,842,711.23
投资活动现金流出小计10,459,979,779.627,338,996,949.662,713,917,920.761,474,723,859.12
投资活动产生的现金流量净额-7,560,533,563.71-5,781,965,276.3-1,562,107,791.18-1,222,881,147.89
筹资活动现金流入小计7,090,611,257.546,220,542,405.154,831,581,352.732,512,227,893.72
筹资活动现金流出小计11,031,994,942.279,524,529,824.837,447,523,962.282,363,325,601.52
筹资活动产生的现金流量净额-3,941,383,684.73-3,303,987,419.68-2,615,942,609.55148,902,292.2
汇率变动对现金及现金等价物的影响132,139,998.6231,612,284.73181,005,246.33-69,410,656.48
现金及现金等价物净增加额2,017,134,528.931,462,447,448.321,601,135,579.751,883,939,746.01
期末现金及现金等价物余额10,001,038,812.029,446,351,731.419,585,039,862.849,867,844,029.1
最新报告期:2024-03-31
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
长江证券郭心驰3.123.473.932024-03-31
首创证券王斌,陈智博3.243.734.262024-03-28
海通证券周航,余文心,贺文斌3.263.674.172024-03-26
中信建投证券刘若飞,贺菊颖3.223.574.012024-03-26
国信证券张佳博,彭思宇3.183.634.142024-03-25
TOP↑